Renovorx(Rnxt) Financials: Payables Turnover Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

fixed asset turnover payables turnover receivables turnover total asset turnover working capital turnover

Growth Trend (Last 5 Years)

Growth - payables turnover

This chart shows the historical trend of payables turnover for RNXT compared to its industry average over the recent years.

Ratio Definition and Interpretation

Name: Payables Turnover

Definition: Payables turnover shows how fast the company pays its suppliers for goods or services bought on credit. A high turnover means the company pays suppliers quickly, which may reflect strong cash flow or favorable terms. A very low turnover might mean the company is stretching payments to preserve cash — or possibly experiencing financial strain.

Interpretation:
• In '2023', RNXT's payables turnover was 0.00, indicating how promptly the company pays its suppliers. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 1.93.
• In '2024', RNXT's payables turnover was 0.00, indicating how promptly the company pays its suppliers. The figure remained stable compared to '2023'. Industry average for Biotechnology: Pharmaceutical Preparations in '2024' stood at 2.39. Industry average increased by 0.45 compared to previous year.
Overall, RNXT's payables turnover has remained generally stable over the past 2 years.

Formula: Payables Turnover = Cost of Goods Sold / Average Accounts Payable

Good Range: Ranges 5-15 depending on industry.